MedTrace Logo

Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson's Disease

NCT02305147 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2025-01-23

No results posted yet for this study

Summary

Observational, prospective, monocentric study to assess clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients and rate of progression compared to healthy controls (HC) and subjects at risk to develop PD.

The primary objective of this study is to identify clinical, imaging and biologic markers of PD onset and progression for use in clinical trials of disease-modifying therapies.

Conditions

  • Parkinson Disease

Interventions

OTHER

Clinical, biological and imaging followup

Assessment of motor and non motor signs every 12 months. Imaging and blood, cerebral fluid, stools and skin samples for identification of biomarkers of disease phenotype and progression.

Sponsors & Collaborators

  • IHU-A-ICM, Paris, France

    collaborator UNKNOWN

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Marie VIDAILHET, PhD · Assistance Publique - Hôpitaux de Paris, FRANCE

  • Jean-Christophe CORVOL, PhD · Assistance Publique - Hôpitaux de Paris, FRANCE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-06
Primary Completion
2029-11-06
Completion
2029-11-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02305147 on ClinicalTrials.gov